scholarly journals Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic Cells

2015 ◽  
Vol 195 (5) ◽  
pp. 2216-2223 ◽  
Author(s):  
Jürgen Brück ◽  
Steve Pascolo ◽  
Kerstin Fuchs ◽  
Christina Kellerer ◽  
Ivana Glocova ◽  
...  
2020 ◽  
Vol 479 ◽  
pp. 112748
Author(s):  
Mieke F. van Essen ◽  
Nicole Schlagwein ◽  
Daniëlle J. van Gijlswijk-Janssen ◽  
Jacqueline D.H. Anholts ◽  
Michael Eikmans ◽  
...  

2007 ◽  
Vol 178 (9) ◽  
pp. 5454-5464 ◽  
Author(s):  
Alexander T. Prechtel ◽  
Nadine M. Turza ◽  
Alexandros A. Theodoridis ◽  
Alexander Steinkasserer

2018 ◽  
Vol 93 (4) ◽  
Author(s):  
Miao Jiang ◽  
Pamela Österlund ◽  
Veera Westenius ◽  
Deyin Guo ◽  
Minna M. Poranen ◽  
...  

ABSTRACTInfluenza A viruses (IAVs) are viral pathogens that cause epidemics and occasional pandemics of significant mortality. The generation of efficacious vaccines and antiviral drugs remains a challenge due to the rapid appearance of new influenza virus types and antigenic variants. Consequently, novel strategies for the prevention and treatment of IAV infections are needed, given the limitations of the presently available antivirals. Here, we used enzymatically produced IAV-specific double-stranded RNA (dsRNA) molecules andGiardia intestinalisDicer for the generation of a swarm of small interfering RNA (siRNA) molecules. The siRNAs target multiple conserved genomic regions of the IAVs. In mammalian cells, the produced 25- to 27-nucleotide-long siRNA molecules are processed by endogenous Dicer into 21-nucleotide siRNAs and are thus designated Dicer-substrate siRNAs (DsiRNAs). We evaluated the efficacy of the above DsiRNA swarm at preventing IAV infections in human primary monocyte-derived macrophages and dendritic cells. The replication of different IAV strains, including avian influenza H5N1 and H7N9 viruses, was significantly inhibited by pretransfection of the cells with the IAV-specific DsiRNA swarm. Up to 7 orders of magnitude inhibition of viral RNA expression was observed, which led to a dramatic inhibition of IAV protein synthesis and virus production. The IAV-specific DsiRNA swarm inhibited virus replication directly through the RNA interference pathway although a weak induction of innate interferon responses was detected. Our results provide direct evidence for the feasibility of the siRNA strategy and the potency of DsiRNA swarms in the prevention and treatment of influenza, including the highly pathogenic avian influenza viruses.IMPORTANCEIn spite of the enormous amount of research, influenza virus is still one of the major challenges for medical virology due to its capacity to generate new variants, which potentially lead to severe epidemics and pandemics. We demonstrated here that a swarm of small interfering RNA (siRNA) molecules, including more than 100 different antiviral RNA molecules targeting the most conserved regions of the influenza A virus genome, could efficiently inhibit the replication of all tested avian and seasonal influenza A variants in human primary monocyte-derived macrophages and dendritic cells. The wide antiviral spectrum makes the virus-specific siRNA swarm a potentially efficient treatment modality against both avian and seasonal influenza viruses.


2009 ◽  
Vol 84 (5) ◽  
pp. 2490-2501 ◽  
Author(s):  
Sandesh Subramanya ◽  
Sang-Soo Kim ◽  
Sojan Abraham ◽  
Jiahong Yao ◽  
Mukesh Kumar ◽  
...  

ABSTRACT Dengue is a common arthropod-borne flaviviral infection in the tropics, for which there is no vaccine or specific antiviral drug. The infection is often associated with serious complications such as dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS), in which both viral and host factors have been implicated. RNA interference (RNAi) is a potent antiviral strategy and a potential therapeutic option for dengue if a feasible strategy can be developed for delivery of small interfering RNA (siRNA) to dendritic cells (DCs) and macrophages, the major in vivo targets of the virus and also the source of proinflammatory cytokines. Here we show that a dendritic cell-targeting 12-mer peptide (DC3) fused to nona-d-arginine (9dR) residues (DC3-9dR) delivers siRNA and knocks down endogenous gene expression in heterogenous DC subsets, (monocyte-derived DCs [MDDCs], CD34+ hematopoietic stem cell [HSC])-derived Langerhans DCs, and peripheral blood DCs). Moreover, DC3-9dR-mediated delivery of siRNA targeting a highly conserved sequence in the dengue virus envelope gene (siFvED) effectively suppressed dengue virus replication in MDDCs and macrophages. In addition, DC-specific delivery of siRNA targeting the acute-phase cytokine tumor necrosis factor alpha (TNF-α), which plays a major role in dengue pathogenesis, either alone or in combination with an antiviral siRNA, significantly reduced virus-induced production of the cytokine in MDDCs. Finally to validate the strategy in vivo, we tested the ability of the peptide to target human DCs in the NOD/SCID/IL-2Rγ−/− mouse model engrafted with human CD34+ hematopoietic stem cells (HuHSC mice). Treatment of mice by intravenous (i.v.) injection of DC3-9dR-complexed siRNA targeting TNF-α effectively suppressed poly(I:C)-induced TNF-α production by DCs. Thus, DC3-9dR can deliver siRNA to DCs both in vitro and in vivo, and this delivery approach holds promise as a therapeutic strategy to simultaneously suppress virus replication and curb virus-induced detrimental host immune responses in dengue infection.


2003 ◽  
Vol 171 (2) ◽  
pp. 691-696 ◽  
Author(s):  
Jonathan A. Hill ◽  
Thomas E. Ichim ◽  
Kornel P. Kusznieruk ◽  
Mu Li ◽  
Xuyan Huang ◽  
...  

2006 ◽  
Vol 177 (2) ◽  
pp. 885-895 ◽  
Author(s):  
Yvette Stallwood ◽  
Emmanuel Briend ◽  
Katrina M. Ray ◽  
George A. Ward ◽  
Beverley J. Smith ◽  
...  

2006 ◽  
Vol 311 (1-2) ◽  
pp. 139-152 ◽  
Author(s):  
Alexander T. Prechtel ◽  
Nadine M. Turza ◽  
Alexandros A. Theodoridis ◽  
Mirko Kummer ◽  
Alexander Steinkasserer

2008 ◽  
Vol 337 (1) ◽  
pp. 71-77 ◽  
Author(s):  
Jonathan Jantsch ◽  
Nadine Turza ◽  
Melanie Volke ◽  
Kai-Uwe Eckardt ◽  
Michael Hensel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document